STOCK TITAN

[Form 4] Credo Technology Group Holding Ltd Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Very Negative)
Form Type
4
Rhea-AI Filing Summary

Vice President James D. Stockman filed a Form 4 for Dillard’s (DDS). On 07/28/2025 he acquired 13 Class A common shares at $513 each (≈ $6.7 k). His direct ownership rises to 35,242 shares; an additional 21,093 shares are held in a retirement plan. The filing uses transaction code “A,” indicating an award or employee-related acquisition rather than an open-market buy. The purchase increases Stockman’s direct stake by 0.04 % and is immaterial relative to DDS’s share count, so market impact should be minimal.

Il vicepresidente James D. Stockman ha presentato un Modulo 4 per Dillard’s (DDS). Il 28/07/2025 ha acquisito 13 azioni ordinarie di Classe A al prezzo di $513 ciascuna (circa $6,7k). La sua posizione diretta sale a 35.242 azioni; ulteriori 21.093 azioni sono detenute in un piano pensionistico. La segnalazione utilizza il codice transazione “A”, che indica un premio o un’acquisizione legata all’impiego, non un acquisto sul mercato aperto. L’acquisto aumenta la quota diretta di Stockman dello 0,04% ed è irrilevante rispetto al totale azionario di DDS, quindi l’impatto sul mercato dovrebbe essere minimo.

El vicepresidente James D. Stockman presentó un Formulario 4 para Dillard’s (DDS). El 28/07/2025 adquirió 13 acciones ordinarias Clase A a $513 cada una (≈ $6,7 mil). Su propiedad directa aumenta a 35,242 acciones; otras 21,093 acciones están en un plan de retiro. La presentación usa el código de transacción “A”, indicando una adjudicación o adquisición relacionada con el empleo, no una compra en mercado abierto. La compra incrementa la participación directa de Stockman en un 0,04% y es insignificante respecto al número total de acciones de DDS, por lo que el impacto en el mercado debería ser mínimo.

부사장 James D. StockmanDillard’s (DDS)에 대한 Form 4를 제출했습니다. 2025년 7월 28일에 그는 클래스 A 보통주 13주를 각각 $513에 취득했습니다(약 $6.7천). 그의 직접 소유주식35,242주로 증가했으며, 추가로 21,093주는 퇴직연금계획에 보유 중입니다. 제출서류는 거래 코드 “A”를 사용했는데, 이는 공개 시장에서의 매수가 아닌 보상 또는 직원 관련 취득을 의미합니다. 이번 매수로 Stockman의 직접 지분이 0.04% 증가했으며 DDS 총 주식수 대비 미미한 수준이므로 시장에 미치는 영향은 최소일 것입니다.

Le vice-président James D. Stockman a déposé un formulaire 4 pour Dillard’s (DDS). Le 28/07/2025, il a acquis 13 actions ordinaires de classe A au prix de 513 $ chacune (environ 6,7 k$). Sa possession directe s’élève désormais à 35 242 actions ; 21 093 actions supplémentaires sont détenues dans un plan de retraite. Le dépôt utilise le code de transaction « A », indiquant une attribution ou une acquisition liée à l’emploi, et non un achat sur le marché libre. Cet achat augmente la participation directe de Stockman de 0,04 % et est négligeable par rapport au nombre total d’actions de DDS, de sorte que l’impact sur le marché devrait être minimal.

Vizepräsident James D. Stockman reichte ein Formular 4 für Dillard’s (DDS) ein. Am 28.07.2025 erwarb er 13 Class A Stammaktien zu je $513 (ca. $6,7 Tsd.). Sein direkter Besitz steigt auf 35.242 Aktien; weitere 21.093 Aktien sind in einem Altersvorsorgeplan gehalten. Die Meldung verwendet den Transaktionscode „A“, was auf eine Zuteilung oder eine mit dem Arbeitsverhältnis verbundene Erwerbung und nicht auf einen Kauf am offenen Markt hinweist. Der Erwerb erhöht Stockmans direkten Anteil um 0,04 % und ist im Verhältnis zur Gesamtzahl der DDS-Aktien unbedeutend, sodass die Marktauswirkung minimal sein sollte.

Positive
  • Insider acquisition, even if small, can be interpreted as modest confidence in DDS’s prospects.
Negative
  • None.

Insights

TL;DR — Small insider buy; minimal valuation impact.

The purchase adds just 13 shares to Stockman’s 35 k-share position, lifting his direct stake by roughly US$6.7 k. That is negligible against DDS’s daily dollar volume and market cap, so I view the filing as neutral. Still, any insider acquisition—however small—leans incrementally positive for sentiment, as it shows continued alignment with shareholders.

TL;DR — Routine Section 16 reporting; no governance red flags.

The Form 4 simply documents an employee-plan award. No derivative instruments, gifting, or dispositions were disclosed, and Stockman remains an officer in good standing. Compliance appears timely and accurate, suggesting sound internal controls. From a governance standpoint, the event is non-material and does not alter risk assessment.

Il vicepresidente James D. Stockman ha presentato un Modulo 4 per Dillard’s (DDS). Il 28/07/2025 ha acquisito 13 azioni ordinarie di Classe A al prezzo di $513 ciascuna (circa $6,7k). La sua posizione diretta sale a 35.242 azioni; ulteriori 21.093 azioni sono detenute in un piano pensionistico. La segnalazione utilizza il codice transazione “A”, che indica un premio o un’acquisizione legata all’impiego, non un acquisto sul mercato aperto. L’acquisto aumenta la quota diretta di Stockman dello 0,04% ed è irrilevante rispetto al totale azionario di DDS, quindi l’impatto sul mercato dovrebbe essere minimo.

El vicepresidente James D. Stockman presentó un Formulario 4 para Dillard’s (DDS). El 28/07/2025 adquirió 13 acciones ordinarias Clase A a $513 cada una (≈ $6,7 mil). Su propiedad directa aumenta a 35,242 acciones; otras 21,093 acciones están en un plan de retiro. La presentación usa el código de transacción “A”, indicando una adjudicación o adquisición relacionada con el empleo, no una compra en mercado abierto. La compra incrementa la participación directa de Stockman en un 0,04% y es insignificante respecto al número total de acciones de DDS, por lo que el impacto en el mercado debería ser mínimo.

부사장 James D. StockmanDillard’s (DDS)에 대한 Form 4를 제출했습니다. 2025년 7월 28일에 그는 클래스 A 보통주 13주를 각각 $513에 취득했습니다(약 $6.7천). 그의 직접 소유주식35,242주로 증가했으며, 추가로 21,093주는 퇴직연금계획에 보유 중입니다. 제출서류는 거래 코드 “A”를 사용했는데, 이는 공개 시장에서의 매수가 아닌 보상 또는 직원 관련 취득을 의미합니다. 이번 매수로 Stockman의 직접 지분이 0.04% 증가했으며 DDS 총 주식수 대비 미미한 수준이므로 시장에 미치는 영향은 최소일 것입니다.

Le vice-président James D. Stockman a déposé un formulaire 4 pour Dillard’s (DDS). Le 28/07/2025, il a acquis 13 actions ordinaires de classe A au prix de 513 $ chacune (environ 6,7 k$). Sa possession directe s’élève désormais à 35 242 actions ; 21 093 actions supplémentaires sont détenues dans un plan de retraite. Le dépôt utilise le code de transaction « A », indiquant une attribution ou une acquisition liée à l’emploi, et non un achat sur le marché libre. Cet achat augmente la participation directe de Stockman de 0,04 % et est négligeable par rapport au nombre total d’actions de DDS, de sorte que l’impact sur le marché devrait être minimal.

Vizepräsident James D. Stockman reichte ein Formular 4 für Dillard’s (DDS) ein. Am 28.07.2025 erwarb er 13 Class A Stammaktien zu je $513 (ca. $6,7 Tsd.). Sein direkter Besitz steigt auf 35.242 Aktien; weitere 21.093 Aktien sind in einem Altersvorsorgeplan gehalten. Die Meldung verwendet den Transaktionscode „A“, was auf eine Zuteilung oder eine mit dem Arbeitsverhältnis verbundene Erwerbung und nicht auf einen Kauf am offenen Markt hinweist. Der Erwerb erhöht Stockmans direkten Anteil um 0,04 % und ist im Verhältnis zur Gesamtzahl der DDS-Aktien unbedeutend, sodass die Marktauswirkung minimal sein sollte.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cheng Chi Fung

(Last) (First) (Middle)
110 RIO ROBLES

(Street)
SAN JOSE CA 95134

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Credo Technology Group Holding Ltd [ CRDO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Technology Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 07/28/2025 S(1) 7,046 D $104.0213(2) 7,211,915 I Cheng Huang Family Trust(3)
Ordinary Shares 07/28/2025 S(1) 16,078 D $104.9481(4) 7,195,837 I Cheng Huang Family Trust(3)
Ordinary Shares 07/28/2025 S(1) 14,468 D $105.9856(5) 7,181,369 I Cheng Huang Family Trust(3)
Ordinary Shares 07/28/2025 S(1) 11,574 D $106.8258(6) 7,169,795 I Cheng Huang Family Trust(3)
Ordinary Shares 07/28/2025 S(1) 5,834 D $107.8278(7) 7,163,961 I Cheng Huang Family Trust(3)
Ordinary Shares 116,890 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Cheng Huang Family Trust on September 6, 2024.
2. This transaction was executed in multiple trades at prices ranging from $103.47 to $104.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. Represents ordinary shares held by the Cheng Huang Family Trust of which the Reporting Person and his spouse are trustees and the Reporting Person, his spouse and their children are beneficiaries. The Reporting Person disclaims beneficial ownership except to the extent of his and his spouse's pecuniary interest therein. The full name of the trust is the Cheng Huang Family Trust U/T/A DTD 12/22/2003.
4. This transaction was executed in multiple trades at prices ranging from $104.47 to $105.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
5. This transaction was executed in multiple trades at prices ranging from $105.47 to $106.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
6. This transaction was executed in multiple trades at prices ranging from $106.48 to $107.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
7. This transaction was executed in multiple trades at prices ranging from $107.49 to $107.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Remarks:
/s/ James Laufman, attorney-in-fact 07/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DDS insider James D. Stockman report in the latest Form 4?

He acquired 13 Class A shares on 07/28/25 at $513, raising his direct holdings to 35,242 shares.

How large is Stockman’s total ownership in Dillard’s?

After the transaction he directly owns 35,242 shares and holds 21,093 more in a retirement plan.

Was this an open-market purchase?

No. Transaction code “A” indicates an award or employee-plan acquisition, not an open-market buy.

Is the reported transaction material to DDS investors?

The ~$6.7 k purchase equals 0.04 % of Stockman’s direct stake and is immaterial to DDS’s float, so market impact is expected to be negligible.

Does the filing reveal any derivative activity or sales?

No. Table II shows zero derivative transactions, and no sales were reported.
CREDO TECHNOLOGY GROUP HOLDING

NASDAQ:CRDO

CRDO Rankings

CRDO Latest News

CRDO Latest SEC Filings

CRDO Stock Data

18.77B
146.86M
15.15%
76.03%
5.19%
Semiconductors
Semiconductors & Related Devices
Link
Cayman Islands
GRAND CAYMAN